triazoles has been researched along with Spinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canivet, JL; De Pasqual, A; Deprez, M; Frère, P; Ghaye, B; Hayette, MP; Kaschten, B; Martin, D; Radermecker, M | 1 |
| Marr, KA; Shoham, S | 1 |
2 other study(ies) available for triazoles and Spinal Diseases
| Article | Year |
|---|---|
[Invasive pulmonary mucormycosis with invasion of the thoracic spine in a patient with myelodysplastic syndrome].
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Immunocompromised Host; Laminectomy; Lung Diseases, Fungal; Male; Mucormycosis; Myelodysplastic Syndromes; Spinal Diseases; Thoracic Vertebrae; Triazoles | 2008 |
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Centers for Disease Control and Prevention, U.S.; Drug Contamination; Fungi; Humans; Iatrogenic Disease; Injections, Spinal; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Referral and Consultation; Spinal Diseases; Spinal Puncture; Triazoles; United States; Voriconazole | 2013 |